To statistically assess the hypothesis that positive TMEM79 expression is inversely associated to prostate cancer, a two-way contingency table was set up (Table 4), which classified the test variables into categories; benign tissue versus tumor (Gleason grade 2–5 and metastasis). This evidence concerns the gene TMEM79 and prostate carcinoma.